Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis [2]

Journal of Neurology

Volumn 251, Issue 7, 2004, Pages 885-886

  Oka, Yasunori ^a   Kanbayashi, Takashi ^b   Mezaki, Takahiro ^a   Iseki, Kazumi ^a   Matsubayashi, Jun ^a   Murakami, Gaku ^a   Matsui, Masaru ^a   Shimizu, Tetsuo ^b   Shibasaki, Hiroshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; OREXIN A;

ADULT; CASE REPORT; CATAPLEXY; CEREBROSPINAL FLUID; CLINICAL EXAMINATION; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERSOMNIA; HYPOTHALAMUS LESION; LABORATORY TEST; LETTER; MULTIPLE SCLEROSIS; NARCOLEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; CARRIER PROTEINS; DISORDERS OF EXCESSIVE SOMNOLENCE; DOWN-REGULATION; FEMALE; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; NEUROPEPTIDES; REM SLEEP PARASOMNIAS; TREATMENT OUTCOME;

EID: 3442894799     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. Beuckmann CT, Yanagisawa M (2002) Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation. J Mol Med 80:329-342
2. International classification of sleep disorders (1997) Diagnostic and coding manual, revised. American Sleep Disorders Association, Rochester
3. Iseki K, Mezaki T, Oka Y, et al. (2002) Hypersomnia in multiple sclerosis. Neurology 59:2006
4. Kanbayashi T, Inoue Y, Chiba S, et al. (2002) CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res 11:91-93
5. Kanbayashi T, Ishiguro H, Aizawa R, et al. (2002) Hypocretin-1 (Orexin-A) concentration in cerebrospinal fluid are low in patients with Guillain-Barré syndrome. Psychiatry Clin Neurosci 56:273-274
6. Kato T, Kanbayashi T, Yamamoto K, et al. (2003) Hypersomnia and Low CSF Hypocretin-1 (Orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Intern Med 42:743-745
7. Kubota H, Kanbayashi T, Tanabe Y, Takanashi I, Kohno Y (2002) A case of acute disseminated encephalomyelitis presenting hypersomnia with decreased hypocretin level in cerebrospinal fluid. J Child Neurol 17:537-539
8. Mignot E, Lammers GJ, Okun M, et al. (2002) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59:1553-1562
9. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin deficiency in human narcolepsy. Lancet 355:39-40
10. Nishino S, Ripley B, Overeem S, et al. (2001) Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 50: 381-388
11. Ripley B, Overeem S, Fujiki N, et al. (2001) CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57:2253-2258
12. Scammell TE, Nishino S, Mignot E, Saper CB (2001) Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke. Neurology 56:1751-1753